NETEC Resource Library

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of FRESENIUS PROPOVEN 2% Emulsion

Item

Click for External Resource*

https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs

*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.

Files for Download

HCP Fact Sheet.pdfHCP Fact Sheet.pdf

Item Type

Guide

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Document Viewer

Share this page:

Was this resource helpful?


Title

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of FRESENIUS PROPOVEN 2% Emulsion

Description

EUA: To maintain sedation via continuous infusion in patients older than age 16 with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting 2

Date

2020-05-08

Citation

Download Heathcare Providers Fact Sheet directly: https://www.fda.gov/media/137889/download

Download Patients, Parents, and Caregivers Fact Sheet directly: https://www.fda.gov/media/137890/download

Collection